ArticleFrontiers in oncology2022

Development and validation of a novel hypoxia-related signature for prognostic and immunogenic evaluation in head and neck squamous cell carcinoma.

Su-Ran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.